SCHEMBL7300673

SCHEMBL7300673

CCCCc1nc(C(C)O)c(C(=O)OCC)[nH]1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
ALDH1A1 P00352 5/20 0.40
HTT P42858 2/20 0.40
HPGD P15428 2/20 0.40
KDM4E B2RXH2 2/20 0.40
RECQL P46063 1/20 0.40
MAPT P10636 1/20 0.39
LMNA P02545 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
MAPK1 P28482 1/20 0.39
POLB P06746 1/20 0.34
KMT2A Q03164 1/20 0.34
GPR84 Q9NQS5 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4371738 0.92 CYP1A2 (0.44) CYP1A2CYP2C9CYP2C19ALDH1A1HTT
SCHEMBL7908334 0.83 PARP1 (0.38) ALDH1A1MAPK1GPR84
SCHEMBL8562993 0.82 ALDH1A1 (0.43) CYP1A2CYP2C9CYP2C19ALDH1A1HTT
SCHEMBL27431049 0.82 GPR84 (0.36) ALDH1A1MAPK1GPR84
SCHEMBL9308698 0.81 ALDH1A1 (0.45) CYP1A2CYP2C9CYP2C19ALDH1A1HTT
SCHEMBL7309807 0.80 ALDH1A1 (0.44) CYP1A2CYP2C9CYP2C19ALDH1A1HTT
SCHEMBL2472768 0.80 ALDH1A1 (0.41) CYP1A2CYP2C9CYP2C19ALDH1A1HTT
SCHEMBL7423269 0.79 ALDH1A1 (0.43) CYP1A2CYP2C9CYP2C19ALDH1A1HTT
SCHEMBL9206394 0.79 ALDH1A1 (0.61) CYP1A2CYP2C9CYP2C19ALDH1A1HTT
SCHEMBL9308574 0.79 ALDH1A1 (0.43) CYP1A2CYP2C9CYP2C19ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1121859-C Process for preparing pharmaceutical composition for treatment or prevention hypertension SNAKYO CO LTD (JP) 2003-09-24 CN disclosed
CN-1101384-C Process for preparing 1-biphenylmethylimidazole derivatives SANKYO CO (JP) 2003-02-12 CN disclosed
EP-0503785-B1 1-Biphenylimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-04-25 EP disclosed
EP-0545912-B1 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-04-25 EP disclosed
CN-1045770-C Process for preparing 1-biphenylmethylimidazole derivatives SANKYO CO (JP) 1999-10-20 CN disclosed
CN-1189490-A Process for preparing 1-biphenylmethylimidazole derivatives SANKYO CO (JP) 1998-08-05 CN disclosed
CN-1188645-A Process for preparing pharmaceutical composition for treatment or prevention hypertension SNAKYO CO LTD (JP) 1998-07-29 CN disclosed
US-5646171-A HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 1997-07-08 US disclosed
US-5616599-A HYPOTENSIVE AGENTS FOR CARDIOVASCULAR DISORDER SANKYO COMPANY, LIMITED (JP) 1997-04-01 US disclosed
EP-0545912-A2 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use Sankyo Company Limited (JP) 1993-06-09 EP disclosed
CN-1065063-A 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1992-10-07 CN disclosed
EP-0503785-A1 1-Biphenylimidazole derivatives, their preparation and their therapeutic use Sankyo Company Limited (JP) 1992-09-16 EP disclosed